Comparison of efficacy of oral ciprofloxacin versus IV eftriaxone in acute uncomplicated pyelonephritis

Authors

Hamid Ziae,*, ShahRokh Mosavi, Raheb GhorbaniRaheb Ghorbani ORCID
*Corresponding Author: Email: [email protected]

Koomesh:Vol. 4, issue 1; 91-95
Published online:Aug 30, 2002
Article type:Research Article
How to Cite:Ziae H, Mosavi S, Ghorbani R. Comparison of efficacy of oral ciprofloxacin versus IV eftriaxone in acute uncomplicated pyelonephritis. koomesh. 2002;4(1):e151969. doi:

Abstract

Introdution: Acute pyelonephritis is one of the bacteri al infections which is treated th rough injection drugs. As, using IV antibiotics has a lot of exp ens e, thus this study was performed to compare the treatment efficacy of two regimens. IV an d oral regimen and alternating oral instead of IV tre atment. Materials and Methods: This clinical trial study was carried out on 54 patients with acute pyelonephritis without any complication in Fatemieh hospital from Au g. 2002. Randomly each patient was prescribed one of the two regimes: oral ciprotloxacin (Regimen I) and IV Ceft riaxon (Regimen II). Seven pa tients from Regimes I, due to th e incomplet e treatment with th e given medicine were set aside. And the rest o f the cases, 24 , 48 and 72 hours after beginning the treatment were ch ecked for disappearing or continuing the fev er and clinic a l symp toms. Chisqure and t tests were used in the meaningful level of 5% to analyse the data. Results: Age mean and standard deviation for regimen. o ne were 50.40 ± 18.7 and fo r II 33 .2 ± 22.4, showing no meaningful difference statistically. Both regimens were hemogenious from gender distribution. Response to treatment was 95% and 100% respectively and showing no meaningful differen ce statistically. But the duration response mean (st and a rd di viation ) to tre a tmen t in both regimen were 2.67 ± 0.49 days and 1.6 ± 0.63 respectively. And h aving meaningful difference statistically ( P =0.0(0). Conclusion: This study showing that o r a l ciprof!oxa cin is as effec t ive as IV ceftr ia xo n, however, the response speed to treatment has been less .

Copyright

© 2002, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

30
Apr
2010

Comparing Ceftriaxone and Cefazolin for Treatment of Adult Acute Pyelonephritis; A Clinical Trial

Azadeh Ebrahimzadeh,
Seyed Alireza Saadatjoo,
Azadeh Alipoor Tabrizi

Ebrahimzadeh A, Saadatjoo SA, Alipoor Tabrizi A. Comparing Ceftriaxone and Cefazolin for Treatment of Adult Acute Pyelonephritis; A Clinical Trial. Arch Clin Infect Dis. 2010;5(2):. doi:

15
Aug
2000

Evaluation of the ciprofloxacin effect on resistant isolates of Pseudomonas aeruginosa in In-vitro and In-vivo

AliAkbar Shabani,
Nasrin Masomi,
Saeid AlAgha

Shabani A, Masomi N, AlAgha S. Evaluation of the ciprofloxacin effect on resistant isolates of Pseudomonas aeruginosa in In-vitro and In-vivo. koomesh. 2000;1(4):e151909. doi:

31
Aug
2025
Daily vs. Every-Other-Day Antibiotic Prophylaxis in Children with Vesicoureteral Reflux: A Randomized Clinical Trial

Daily vs. Every-Other-Day Antibiotic Prophylaxis in Children with Vesicoureteral Reflux: A Randomized Clinical Trial

Nastran Malakuti,
Saed Mohajeri,
Hadi Raeisi Shahraki,
Alizamen Salehifardjouneghani

Malakuti N, Mohajeri S, Raeisi Shahraki H, Salehifardjouneghani A. Daily vs. Every-Other-Day Antibiotic Prophylaxis in Children with Vesicoureteral Reflux: A Randomized Clinical Trial. Jundishapur J Nat Pharm Prod. 2025;20(4):e165012. doi: https://doi.org/10.5812/jjnpp-165012

19
Feb
2019

Comparison of Intravenous Ibuprofen with Intravenous Ketorolac in Renal Colic Pain Management; A Clinical Trial

Mohammad Mehdi Forouzanfar,
Khaghan Mohammadi,
Behrouz Hashemi,
Saeed Safari

Forouzanfar MM, Mohammadi K, Hashemi B, Safari S. Comparison of Intravenous Ibuprofen with Intravenous Ketorolac in Renal Colic Pain Management; A Clinical Trial. Anesth Pain Med. 2019;9(1):e86963. doi: https://doi.org/10.5812/aapm.86963

17
Jul
2018
Paracetamol vs. Intravenous Morphine Plus Diclofenac in Renal Colic Pain: A Randomized Clinical Trial

Paracetamol vs. Intravenous Morphine Plus Diclofenac in Renal Colic Pain: A Randomized Clinical Trial

Samad Shams-Vahdati,
Navideh Robaei,
Paria Habibollah,
Asghar Jafari-Rouhi,
Sahar Mohammadi,
Reza Piri

Shams-Vahdati S, Robaei N, Habibollah P, Jafari-Rouhi A, Mohammadi S, et al. Paracetamol vs. Intravenous Morphine Plus Diclofenac in Renal Colic Pain: A Randomized Clinical Trial. Nephro-Urol Mon. 2018;10(4):e77193. doi: https://doi.org/10.5812/numonthly.77193

More by these authors

Hamid ZiaePubMedScholar
ShahRokh MosaviPubMedScholar
Raheb GhorbaniPubMedScholar
Share
Cited by
Metrics